IMARC Group, a leading market research company, has released a report titled “Positive Airway Pressure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. According to the report, The global positive airway pressure devices market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.
Positive airway pressure (PAP) devices are utilized in the treatment of snoring and obstructive sleep apnea (OSA). They also find application in respiratory ventilation to increase the oxygenation of patients in intensive care units (ICUs). They have straps for positioning the mask, hose or tube for connecting the mask to a motor and air filter for purifying the air entering the nostrils. Nowadays, leading manufacturers are introducing automatic PAP devices, which rely on proprietary algorithms to adjust the pressure delivered noninvasively.
Request for a sample copy of this report: https://www.imarcgroup.com/positive-airway-pressure-devices-market/requestsample
Positive Airway Pressure Devices Market Trends and Drivers:
As per studies conducted by various healthcare institutes, PAP devices can be used for treating type 1 respiratory failure among coronavirus disease (COVID-19)patients. Besides this, the shortage of mechanical ventilators is driving the market. Apart from this, the growing prevalence of diabetes, hypertension, depression, and heart disorders is positively influencing the need for developing OSA among individuals. This, along with favorable reimbursement policies, is anticipated to fuel the market growth.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
- Automatic Positive Airway Pressure (APAP) Devices
- Continuous Positive Airway Pressure (CPAP) Devices
- Bi-level Positive Airway Pressure (BiPAP) Devices
Breakup by End User:
- Hospitals and Sleep Labs
- Home Care
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- 3B Medical Inc.
- Apex Medical Corp.
- Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
- Drive Devilbiss Healthcare (Drive International LLC)
- Fisher & Paykel Healthcare Limited
- Koninklijke Philips N.V.
- Resmed Inc.
- Smiths Group Plc
- Somnetics International Inc.
- Vyaire Medical Inc.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=3679&flag=F
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
